Protective effects of ferulic acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 1, 2013, Pages 140-143

  Yan, Ji Jing ^a   Jung, Jun Sub ^a   Kim, Taek Keun ^a   Hasan, Md Ashraful ^a   Hong, Chang Won ^a   Nam, Ju Suk ^a   Song, Dong Keun ^a  

^a Hallym University   (South Korea)

Author keywords

amyloid peptide; Alzheimer disease; Amyloid precursor protein; Ferulic acid; Presenilin 1

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; FERULIC ACID; INTERLEUKIN 1BETA; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; FEMALE; FRONTAL CORTEX; LONG TERM CARE; MOUSE; NEUROPROTECTION; NONHUMAN; TASK PERFORMANCE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; COUMARIC ACIDS; FEMALE; FRONTAL LOBE; INTERLEUKIN-1BETA; MICE; MICE, TRANSGENIC; NEUROPROTECTIVE AGENTS; PRESENILIN-1; RECOGNITION (PSYCHOLOGY);

EID: 84872720134     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00798     Document Type: Article

References (18)

1. Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell, 148, 1204-1222 (2012).
2. Maltsev AV, Bystryak S, Galzitskaya OV. The role of β-amyloid peptide in neurodegenerative diseases. Ageing Res. Rev., 10, 440-452 (2011).
3. Lemere CA, Masliah E. Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat. Rev. Neurol., 6, 108-119 (2010).
4. Graf E. Antioxidant potential of ferulic acid. Free Radic. Biol. Med., 13, 435-448 (1992).
5. Scott BC, Butler J, Halliwell B, Aruoma OI. Evaluation of the antioxidant actions of ferulic acid and catechins. Free Radic. Res. Commun., 19, 241-253 (1993).
6. Fernández MA, Sáenz MT, García MD. Anti-inflammatory activity in rats and mice of phenolic acids isolated from Scrophularia frutescens. J. Pharm. Pharmacol., 50, 1183-1186 (1998).
7. Ozaki Y. Antiinflammatory effect of tetramethylpyrazine and ferulic acid. Chem. Pharm. Bull., 40, 954-956 (1992).
8. Yan JJ, Cho JY, Kim HS, Kim KL, Jung JS, Huh SO, Suh HW, Kim YH, Song DK. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol., 133, 89-96 (2001).
9. Kim HS, Cho JY, Kim DH, Yan JJ, Lee HK, Suh HW, Song DK. Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Biol. Pharm. Bull., 27, 120-121 (2004).
10. Cho JY, Kim HS, Kim DH, Yan JJ, Suh HW, Song DK. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 901-907 (2005).
11. Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA. Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)- induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J. Neurochem., 92, 749-758 (2005).
12. Perluigi M, Joshi G, Sultana R, Calabrese V, De Marco C, Coccia R, Cini C, Butterfield DA. In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J. Neurosci. Res., 84, 418-426 (2006).
13. Ono K, Hirohata M, Yamada M. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro. Biochem. Biophys. Res. Commun., 336, 444-449 (2005).
14. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci., 21, 8370-8377 (2001).
15. Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN. Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J. Neurosci., 22, 2246-2254 (2002).
16. Sarter M, Bodewitz G, Stephens DN. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berl.), 94, 491-495 (1988).
17. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ. Genetic enhancement of learning and memory in mice. Nature, 401, 63-69 (1999).
18. Hamaguchi T, Ono K, Murase A, Yamada M. Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-β aggregation pathway. Am. J. Pathol., 175, 2557-2565 (2009).